Therapeutic antibody adalimumab inhibiting TNF-a, illustration - stock illustration

Illustration of adalimumab (light blue) binding the cytokine tumour necrosis factor-alpha (TNF-a, blue). Adalimumab is a therapeutic monoclonal antibody used to bind excess TNF-a in the body, overproduction of which causes inflammation, swelling, and pain. It is used for the treatment of autoimmune diseases such as rheumatoid and psoriatic arthritis, Crohn's disease and ulcerative colitis
Illustration of adalimumab (light blue) binding the cytokine tumour necrosis factor-alpha (TNF-a, blue). Adalimumab is a therapeutic monoclonal antibody used to bind excess TNF-a in the body, overproduction of which causes inflammation, swelling, and pain. It is used for the treatment of autoimmune diseases such as rheumatoid and psoriatic arthritis, Crohn's disease and ulcerative colitis
Therapeutic antibody adalimumab inhibiting TNF-a, illustration
Buy print
Get this image in a variety of framing options at Photos.com.
PURCHASE A LICENSE
All Royalty-Free licenses include global use rights, comprehensive protection, simple pricing with volume discounts available
kr. 2.200,00
DKK
Getty ImagesTherapeutic Antibody Adalimumab Inhibiting Tnfa Illustration High-Res Vector GraphicTherapeutic Antibody Adalimumab Inhibiting Tnfa Illustration High-Res Vector GraphicDownload premium, authentic Therapeutic antibody adalimumab inhibiting TNF-a, illustration stock illustrations from Getty Images. Explore similar high-resolution stock illustrations in our expansive visual catalogue.Product #:2167923553
kr.2.200kr.280
Getty Images
In stock

DETAILS

Credit:
JUAN GAERTNER/SCIENCE PHOTO LIBRARY
Creative #:
2167923553
License type:
Royalty-free
Collection:
Science Photo Library
Max file size:
6827 x 5120 px (22.76 x 17.07 in) - 300 dpi - 5 MB
Upload date:
Release info:
No release required
Categories: